glp-1 urinary tract infection receptor agonists in diabetic kidney disease: current evidence and future directions Glucagon-like peptide-1 receptor signaling modifies

Back Brown, JC, Mutt, V, Pederson, RA (July 1970) 'Further purification of a polypeptide demonstrating enterogastrone activity', The Journal of Physiology , 209/1

GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro were initially developed to treat type 2 diabetes, but their effectiveness as anti-obesity medications has generated tremendous excitement and high demand among people who have struggled to lose weight by other means

More specifically, among these cases, 19 (48.7%) were associated with liraglutide, 9 (23.1%) with dulaglutide, 4 (10.3%) each with exenatide and semaglutide, while 1 (2.6%) case each was linked to lixisenatide, albiglutide, and tirzepatide

Tocher, Zeling Lin, Bing Chen, Ruixin Li, Shuqi Wang, Cuiying Chen, Houguo Xu Aquaculture Nutrition.2025;[Epub] CrossRef Geranylgeranyl Pyrophosphate Promotes Hepatic Lipid Accumulation by Prenylation of Perilipin4 Yue Zhao, Hong-Yu Nie, Shan Jiang, Meng-Fei Zhao, Peng Sun, Jing-Zi Zhang, Xiao-Chen Wang, Yi-Ping Tang, Ming-jie Zou, Xian-Wen Yuan, Xi-Tai Sun, Xiao-Dong Shan, Jian He, Jiang-Huai Liu, Yan Bi, Lei Fang, Xiao Han, Chao-Jun Li Cellular and Molecular Gastroenterology and Hepatology.2025

Animal experiments All procedures performed in rats were approved by the Institutional Animal Care and Use Committee at the Seattle Childrens Research Institute (IACUC00064) and were in accordance with the National Institutes of Health (NIH) Guide for Care and Use of Laboratory Animals